Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 1.53 g/t Au over 191.3m in infill drilling at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Liquidia Corporation LQDA

Healthcare Biotechnology
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LQDA)

Liquidia Corporation to Present at Upcoming Healthcare Investment Conferences

GlobeNewswire November 3, 2025

Liquidia Corporation Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire November 3, 2025

Liquidia Corporation to Report Third Quarter 2025 Financial Results on November 3, 2025

GlobeNewswire October 27, 2025

Liquidia Corporation to Host R&D Day in New York City on October 28, 2025

GlobeNewswire October 7, 2025

Liquidia to Present Clinical Data from ASCENT Trial at the CHEST 2025 Annual Meeting

GlobeNewswire September 29, 2025

Liquidia Announces Poster Presentations at the Pulmonary Hypertension Professional Association (PHPN) Symposium

GlobeNewswire September 11, 2025

Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

GlobeNewswire August 27, 2025

Liquidia Corporation Reports Second Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire August 12, 2025

Liquidia Corporation to Report Second Quarter 2025 Financial Results on August 12, 2025

GlobeNewswire August 5, 2025
View More News ››

Opinion & Analysis (NDAQ:LQDA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LQDA)

Peekaboo!!

Yeah yeah!!! 
MushLove - January 4, 2022
View more Bullboard ››

Southern Silver Exploration Corp.

Southern Silver Exploration Corp.

Southern Silver Exploration Corp., an exploration stage company, acquires, explores, and develops natural resource properties ...
View More »